Cano Health Inc. (CANO)
NYSE: CANO
· Real-Time Price · USD
2.30
-0.05 (-2.13%)
At close: Feb 02, 2024, 10:00 PM
Cano Health Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 3.1B | 2.98B | 2.9B | 2.74B | 2.55B | 2.41B | 2.12B | 1.69B | 1.46B | 1.2B | 976.41M |
Cost of Revenue | 2.95B | 2.73B | 2.5B | 2.32B | 2.17B | 2.05B | 1.79B | 1.42B | 1.21B | 993.59M | 792.59M |
Gross Profit | 153.12M | 249.11M | 404.16M | 421.89M | 385.13M | 363.31M | 325.46M | 268.38M | 247.46M | 204.78M | 183.83M |
Operating Income | -772.51M | -330.75M | -115.72M | -89.92M | -105.76M | -90.24M | -72.96M | -64.35M | -25.42M | -9.17M | -757K |
Interest Income | 364K | 110K | 22K | 14K | 7K | 4K | 3K | 3K | 84K | 163K | 241K |
Pretax Income | -1.13B | -746.67M | -487.81M | -426.23M | -124.74M | -51.82M | -35.14M | -45.89M | -93.59M | -64.04M | -77.97M |
Net Income | -731.12M | -582.64M | -456.45M | -428.38M | -126M | -28.63M | -4.58M | -14.97M | -62.4M | -58.88M | -79.35M |
Selling & General & Admin | 384.54M | 415.48M | 422.24M | 422.36M | 407.88M | 372.04M | 312.43M | 251.13M | 191.51M | 142.98M | 118.26M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 54.06M | 80.31M | 98.82M | 90.64M | 64.22M | 38.85M | 18.99M | 5.8M | 5.49M | 10.9M | 10.78M |
Operating Expenses | 554.17M | 583.72M | 521.07M | 512.99M | 490.79M | 446.56M | 375.06M | 300.57M | 228.02M | 167.91M | 139.22M |
Interest Expense | 99.5M | 86.3M | 72.72M | 62.5M | 57.8M | 57.37M | 53.95M | 51.29M | 48.64M | 44.96M | 40.96M |
Selling & Marketing Expenses | 11.24M | 11.24M | 11.24M | 11.24M | -64.16M | -64.16M | -64.16M | -64.16M | n/a | n/a | n/a |
Cost & Expenses | 3.5B | 3.31B | 3.02B | 2.83B | 2.66B | 2.5B | 2.17B | 1.72B | 1.44B | 1.16B | 931.81M |
Income Tax Expense | -32.94M | -34.04M | -31.36M | 2.16M | 1.42M | 3.21M | 380K | 14K | -405K | -626K | 1.38M |
Shares Outstanding (Basic) | 5.28M | 5.28M | 5.03M | 4.89M | 4.89M | 4.75M | 4.68M | 1.78M | 1.71M | 1.67M | 1.66M |
Shares Outstanding (Diluted) | 5.28M | 5.28M | 5.03M | 4.89M | 4.89M | 4.75M | 4.68M | 1.78M | 1.71M | 1.69M | 1.66M |
EPS (Basic) | -143.31 | -116.87 | -93.27 | -87.7 | -25.63 | -11.29 | -2.55 | -8.83 | -37.34 | -35.46 | -47.74 |
EPS (Diluted) | -143.31 | -116.87 | -93.27 | -87.7 | -25.63 | -11.29 | -2.61 | -8.89 | -37.4 | -35.52 | -47.74 |
EBITDA | -489.89M | -330.72M | -121.59M | -104.42M | -123.66M | -28.66M | -16.99M | -29.97M | 5.47M | 14.6M | 13.37M |
EBIT | -749.8M | -390.7M | -145.43M | -94.07M | -73.23M | 5.55M | 18.81M | -6.07M | -14.37M | 11.5M | -17.28M |
Depreciation & Amortization | 108.08M | 106.68M | 99.52M | 90.89M | 83.16M | 74.78M | 62.63M | 49.44M | 36.5M | 24.93M | 20.96M |